LUNG CANCER (SCLC)
Clinical trials for LUNG CANCER (SCLC) explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER (SCLC) trials appear
Sign up with your email to follow new studies for LUNG CANCER (SCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Triple-Threat attack on tough lung cancer spread to liver
Disease control Not yet recruitingThis study is testing a three-part treatment for people with a hard-to-treat form of lung cancer that has spread to the liver and has worsened despite previous standard therapies. It combines targeted radiation to the liver with immunotherapy drugs and chemotherapy. The goal is t…
Matched conditions: LUNG CANCER (SCLC)
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Breakthrough scan could match cancer patients to best treatments
Diagnosis Not yet recruitingThis study is testing a new type of PET scan that detects a protein called PD-L1 in tumors. Researchers want to see if this scan can identify which patients with lung cancer, melanoma, or other solid tumors are most likely to benefit from immunotherapy drugs. The scan uses a radi…
Matched conditions: LUNG CANCER (SCLC)
Sponsor: Peking University Cancer Hospital & Institute • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC